Development of metastatic HER2+ breast cancer is independent of the adaptive immune system

The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity

(2010) SaeGwang Park et al.   CANCER CELL

FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis

(2010) Pauline Andreu et al.   CANCER CELL

Adaptive control of innate immunity

(2010) Anil Shanker   IMMUNOLOGY LETTERS

Erbb2 DNA Vaccine Combined with Regulatory T Cell Deletion Enhances Antibody Response and Reveals Latent Low-Avidity T Cells: Potential and Limits of Its Therapeutic Efficacy

(2010) S. Rolla et al.   JOURNAL OF IMMUNOLOGY

A Lymphotoxin-Driven Pathway to Hepatocellular Carcinoma

(2009) Johannes Haybaeck et al.   CANCER CELL

CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages

(2009) David G. DeNardo et al.   CANCER CELL

Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via L-Arginine Metabolism

(2009) L. A. Norian et al.   CANCER RESEARCH

Clinical relevance of the triple-negative breast cancer concept: Genetic basis and clinical utility of the concept

(2009) Sabine C. Linn et al.   EUROPEAN JOURNAL OF CANCER

A tissue reconstitution model to study cancer cell-intrinsic and -extrinsic factors in mammary tumourigenesis

(2009) Bastiaan Evers et al.   JOURNAL OF PATHOLOGY

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design

(2008) Maciej Kmieciak et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?

(2008) Karin E. de Visser   CANCER IMMUNOLOGY IMMUNOTHERAPY

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

(2008) C. Desmedt et al.   CLINICAL CANCER RESEARCH